Bryan Sauer, MD
Gastroenterology · Charlottesville, VANPI 1992917827
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $440,986 of the $540,261 with a category attached, or 81.6%. 5 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 52.2% of the total. 2025 is the largest year on record at $224,812, more than ten times the $2,140 reported in 2021. Among gastroenterology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $1657.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$282K
- Sanofi$248K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Regeneron$4K
- Medtronic$65
What the payments were for
- Consulting fees$35,2877%
- Speaking & faculty fees$440,98682%
- Travel & lodging$57,45511%
- Food & beverage$6,5331%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 197 | $282,023 |
| Sanofi | 117 | $247,745 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $6,287 |
| Regeneron | 2 | $4,141 |
| Medtronic | 1 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$540,261 in reported general payments places this provider in the 95th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $100,022 |
| Fluticasone Propionate HfaFluticasone Propionate | 15 | $6,201 |
| Omeprazole | 102 | $1,317 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $704 |
| Pantoprazole Sodium | 41 | $507 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 34 | $467 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 20 | $381 |
| Esomeprazole Magnesium | 11 | $372 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Charlottesville
- Brian WentworthCharlottesville$276K
- Vanessa ShamiCharlottesville$210K
- David PeuraCharlottesville$103K
- Esteban FigueroaCharlottesville$66K
- Amir RummanCharlottesville$31K
- Michael McCabeCharlottesville$18K
- Fabio CominelliCharlottesville$15K
- Mohammad SiddiquiCharlottesville$15K
- Larry ClarkLynchburg$1.2M
- Arun SanyalRichmond$855K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.